Kopran

Since its inception in the late 1950s, Kopran has established itself as an integrated pharmaceutical manufacturer, supplying quality formulations and Active Pharmaceutical Ingredients (APIs) worldwide. Looking ahead, the company is focused on pursuing sustainable growth by developing premium-quality APIs and Formulations while strengthening its global presence and exploring new opportunities. Its mission is to build a sustainable business by integrating product development, adopting the latest technologies, and upholding the highest standards of quality in manufacturing. The company manufactures diverse Active Pharmaceutical Ingredients (APIs), the key components of medicines, including specialized products like Sterile Cephalosporins and Carbapenems. Its formulations business benefits from in-house API production, giving it a competitive edge through better cost efficiency and quality control for its final medicinal products. Demonstrating its scale, the company's revenue from operations reached ₹61,459 lakhs in FY 2023-24, highlighting its significant market presence.;